{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:34:18Z","timestamp":1761093258414,"version":"build-2065373602"},"reference-count":17,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T00:00:00Z","timestamp":1325808000000},"content-version":"vor","delay-in-days":1831,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2007,1]]},"abstract":"<jats:p>The risk of carbapenem hypersensitivity in patients with self\u2010reported or documented penicillin allergy needs to be determined so that practitioners can make better\u2010informed decisions regarding antibiotic therapy for this patient population. The risk of cross\u2010reactivity between penicillin and carbapenem antibiotics initially was reported to approach 50%. Recent retrospective studies have suggested that the clinical risk of cross\u2010hypersensitivity between these two drug classes is 9.2\u201311%, which is significantly lower than initially reported. Patients whose history of penicillin allergy is self\u2010reported and is not type 1 may be at moderate risk for hypersensitivity when treated with a carbapenem antibiotic. The risk of hypersensitivity appears to be higher in patients whose penicillin allergy was documented by a health care provider, those with several antibiotic allergies, and those with a positive penicillin skin test result or a history of type 1 penicillin hypersensitivity.<\/jats:p>","DOI":"10.1592\/phco.27.1.137","type":"journal-article","created":{"date-parts":[[2006,12,28]],"date-time":"2006-12-28T07:34:50Z","timestamp":1167291290000},"page":"137-141","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical Importance of Carbapenem Hypersensitivity in Patients with Self\u2010Reported and Documented Penicillin Allergy"],"prefix":"10.1002","volume":"27","author":[{"suffix":"Jr.","given":"William A.","family":"Prescott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen A.","family":"Kusmierski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,6]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612033455143"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199410040-00006"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-2-204"},{"volume-title":"Primaxin (imipenem\u2010cilastatin) package insert","year":"2005","author":"Merck & Co.","key":"e_1_2_1_5_2"},{"volume-title":"Merrem (meropenem) package insert","year":"2005","author":"AstraZeneca Pharmaceuticals","key":"e_1_2_1_6_2"},{"volume-title":"Invanz (ertapenem) package insert","year":"2005","author":"Merck & Co.","key":"e_1_2_1_7_2"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.Supplement_E.193"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1988.tb05735.x"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/7.Supplement_3.S528"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(88)91001-9"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/317507"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/382880"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh454"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2498"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.1994.tb09729.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199408000-00007"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.18.2819"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.27.1.137","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.27.1.137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:59:09Z","timestamp":1761044349000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.27.1.137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["10.1592\/phco.27.1.137"],"URL":"https:\/\/doi.org\/10.1592\/phco.27.1.137","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"type":"print","value":"0277-0008"},{"type":"electronic","value":"1875-9114"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"2012-01-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}